Clinical Trial

Effect of Metyrapone on Cardiovascular Risk Factors in Patients With Adrenal Incidentalomas and Cushing's Syndrome

Name: Effect of Metyrapone on Cardiovascular Risk Factors in Patients With Adrenal Incidentalomas and Cushing's Syndrome — clinical trial record (NCT06801249)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

Drug interventional, controlled, randomized open-label, parallel-group, multicenter study in patients with bilateral adrenal incidentalomas associated with subclinical Cushing's syndrome

Trial Details

NCT Number	NCT06801249
Lead Sponsor	IRCCS Azienda Ospedaliero-Universitaria di Bologna
Conditions	Adrenal Incidentalomas, Cushing Syndrome
Enrollment	50 participants
Start Date	2021-02-23
Primary Completion	2024-11-30 (estimated)
Study Completion	2025-02-17 (estimated)
Updated on ClinicalTrials.gov	2025-01-30